MedPath

Comparison between effect of bala tail and tila tail nasya,pichu,pana in nasal obstruction(nasanaha)

Phase 1/2
Not yet recruiting
Conditions
Acute upper respiratory infection,unspecified. Ayurveda Condition: NASAROGAH,
Registration Number
CTRI/2022/06/042996
Lead Sponsor
Patanjali ayurvedic hospital
Brief Summary

This study is a randomized, open-labeled, parallel-group, clinical trial, to compare and evaluate effect of bala tail and tila tail nasya pichu and pana in nasanaha..

Patients suffering with symptoms of nasanaha attending the OPD/IPD of SHALAKYA TANTRA department of Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar will be selected randomly for this clinical study irrespective of sex, religion, occupation etc. A detailed Performa will be prepared on basis of Ayurvedic text and allied sciences. The patient fulfilling the inclusion and exclusion criteria will be registered on this Performa and scoring of different clinical features will be done on the assessment criteria.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • 1.Patients suffering with clinical features of nasanaha (nasal obstruction) 2.
  • Age group between 15 to 60 years 3.Patient having atleast 1-2 associated complaints e.g- headache, nasal discharge ,discomfort in nose, congested nasal mucosa and turbinates and reduced perception of smell 4.
  • Patients yogya for nasya and pichu karma.
Exclusion Criteria
  • Age group below 15 & above 60 years 2 .patients with any other specific reason of nasal obstruction e.g nasal polyp, adenoids hypertrophy, tumours, carcinoma, foreign body, trauma ,any sinonasal surgeries, epistaxis etc.
  • 3 .patients suffering with acute rhinitis or sinusitis.
  • patients suffering with COPD,or any other severe systemic 5.pregnant women and lactating mother.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective Parameter-Grading will be done considering signs & symptoms of nasanaha..For subjective parameter 1st and 30th day
Secondary Outcome Measures
NameTimeMethod
Objective parameter..x ray pns, anterior rhinoscopyFor objective parameter on 1 and 30 thday of trial

Trial Locations

Locations (1)

Patanjali ayurveda hospital

🇮🇳

Hardwar, UTTARANCHAL, India

Patanjali ayurveda hospital
🇮🇳Hardwar, UTTARANCHAL, India
Dr monika mishra
Principal investigator
7248520330
Mmonika851@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.